Elixir Medical Corp, is committed to transform patient care through innovation making a meaningful change in live. Since 2005, the company has continually sought to improve the treatment of vascular disease with: Drug-eluting coronary stent systems (DES), Fully resorbable drug-eluting scaffold systems (BRS) & lately with Drug-eluting coronary bioadaptor systems
Translumina Therapeutics, a company that always explore Limitless Possibilities within the interventional cardiology world, has an ambition to deliver world-class products & services, with superior clinical safety & efficacy, through innovative & breakthrough technologies. Strong clinical evidence and affordable prices are key drivers for improved clinical outcomes.
Blue Medical Devices BV is a Dutch medical devices company founded in 1998 that develops and produces innovative high quality drug eluting solutions such as PTCA balloon catheters. All Blue Medical products are its own design and are produced in its production facility in the Netherlands. Blue Medical is a Translumina company.
Seigla® Medical, an emerging technology company based in Minnesota, was founded by a team of expert designers, developers and manufacturers of medical devices who joined forces in December 2017. Their mission, rooted in listening closely to the needs of interventional physicians, is focused on technologies that meet the challenges of treating vascular disease today and in the future
The Barcelona Tissue Bank, is part of the Banc de Sang i Teixits (Blood and Tissue Bank), a public company owned by the Catalan Government’s Ministry of Health, whose mission is to guarantee supply and good use of blood & tissues. It’s an internationally renowned multi-tissue bank with highly qualified staff aiming to offer the best possible therapeutic response to cover the needs of all patients and professionals, offering very highsafety and quality standards. R &D plus innovation are their constant priorities to ensure the best possible solution to patients.











